Visual Pathway Axonal Loss in Benign Multiple Sclerosis: A Longitudinal Study

Background: Benign multiple sclerosis (MS), traditionally defined as Expanded Disability Status Scale (EDSS) score ⩽3 and ≥15-year disease duration, is thought to follow a milder clinical course. We determined the extent of visual pathway axonal loss by optical coherence tomography (OCT) retinal nerve fiber layer (RNFL) thickness in a benign MS cohort and examined the relation to vision and quality of life (QOL). Methods: In this longitudinal study of vision in MS at 3 academic centers, a subset of patients with EDSS, visual function, OCT, and QOL assessments was analyzed. Low- and high-contrast letter acuity was performed to assess visual function. RNFL thickness was determined using time-domain OCT. QOL scales included the 25-Item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25) and Short Form-36 Health Survey. Results: Among 68 patients (135 eyes) studied longitudinally, 13 (26 eyes) had benign MS using criteria of EDSS score ⩽3 and ≥15-year disease duration. Benign MS eyes had as much RNFL thinning (−3.6 &mgr;m, P = 0.0008 vs baseline, paired t test) as typical MS eyes (−3.3 &mgr;m, P < 0.0001). Both groups had significant low-contrast acuity loss. History of optic neuritis (ON) was more frequent in benign MS (69% vs 33% of eyes). History of ON distinguished benign vs typical MS (P = 0.002) and correlated with RNFL thickness at baseline (P = 0.002) and disease duration (P = 0.03) but not EDSS (P = 0.32, logistic regression). NEI-VFQ-25 scores were also worse for benign MS, accounting for age (75 ± 21 vs 88 ± 11, P = 0.005). Conclusion: Patients with benign MS have RNFL axonal loss that is as marked as that of typical MS and have reduced vision and QOL. While overall neurologic impairment is mild, visual dysfunction, not well captured by the EDSS, accounts for a substantial degree of disability in benign MS.

[1]  M. Filippi,et al.  Global N-Acetylaspartate Declines Even in Benign Multiple Sclerosis , 2010, American Journal of Neuroradiology.

[2]  J. Aarseth,et al.  How long can you keep working with benign multiple sclerosis? , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[3]  M. Battaglini,et al.  Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis , 2010, Multiple sclerosis.

[4]  J. Aarseth,et al.  Benign multiple sclerosis: a need for a consensus , 2010, Acta neurologica Scandinavica. Supplementum.

[5]  G. Ying,et al.  Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis , 2010, Annals of neurology.

[6]  I. Allen,et al.  Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. , 2010, Brain : a journal of neurology.

[7]  Richard A. Rudick,et al.  The Multiple Sclerosis Functional Composite , 2010, Neurology.

[8]  T. Panou,et al.  Benign multiple sclerosis in Crete , 2010, Multiple sclerosis.

[9]  Barbara Spanò,et al.  Multiparametric MR investigation of the motor pyramidal system in patients with ‘truly benign’ multiple sclerosis , 2010, Multiple sclerosis.

[10]  M Filippi,et al.  Preserved brain adaptive properties in patients with benign multiple sclerosis , 2010, Neurology.

[11]  F. Barkhof “Benign” and “normal appearing”: it’s in the eye of the beholder , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  M. Filippo,et al.  Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[13]  A Giorgio,et al.  Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis , 2009, Neurology.

[14]  T. Riise,et al.  Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway , 2009, Multiple sclerosis.

[15]  G. Comi,et al.  A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  G. Comi,et al.  In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis , 2009, Multiple sclerosis.

[17]  M Rovaris,et al.  MRI features of benign multiple sclerosis , 2009, Neurology.

[18]  E. Portaccio,et al.  Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study , 2009, Multiple sclerosis.

[19]  M. Maguire,et al.  Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[20]  Rohit Bakshi,et al.  Rate of brain atrophy in benign vs early multiple sclerosis. , 2009, Archives of neurology.

[21]  Carlos M. Gómez,et al.  Quantitative electroencephalography reveals different physiological profiles between benign and remitting-relapsing multiple sclerosis patients , 2008, BMC neurology.

[22]  Marco Rovaris,et al.  Cognitive impairment and structural brain damage in benign multiple sclerosis , 2008, Neurology.

[23]  G. Siracusa,et al.  Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis , 2008, Neurology.

[24]  S. Gold,et al.  Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable , 2008, Multiple sclerosis.

[25]  M. Hutchinson,et al.  Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[26]  S Ropele,et al.  Clinically benign multiple sclerosis despite large T2 lesion load: Can we explain this paradox? , 2008, Multiple sclerosis.

[27]  A. Thompson,et al.  Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. , 2008, Brain : a journal of neurology.

[28]  G. Ingram,et al.  Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[29]  J. De Keyser,et al.  Predictive value of clinical characteristics for ‘benign’ multiple sclerosis , 2007, European journal of neurology.

[30]  L. Kappos,et al.  Natalizumab reduces visual loss in patients with relapsing multiple sclerosis , 2007, Neurology.

[31]  H. Tremlett,et al.  Longitudinal follow-up of “benign” multiple sclerosis at 20 years , 2007, Neurology.

[32]  M. Maguire,et al.  Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25. , 2006, American journal of ophthalmology.

[33]  M. Battaglini,et al.  Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. , 2006, Brain : a journal of neurology.

[34]  J. De Keyser,et al.  Benign course in multiple sclerosis: a review , 2006, Acta neurologica Scandinavica.

[35]  Sandro Sorbi,et al.  Benign multiple sclerosis , 2006, Journal of Neurology.

[36]  Gary R Cutter,et al.  Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. , 2006, Ophthalmology.

[37]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[38]  À. Rovira,et al.  Is optic neuritis more benign than other first attacks in multiple sclerosis? , 2005, Annals of neurology.

[39]  G V McDonnell,et al.  Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors , 1999, Journal of neurology, neurosurgery, and psychiatry.

[40]  A. Minagar Global N-Acetylaspartate Declines Even in Benign Multiple Sclerosis , 2011 .

[41]  Moses Rodriguez,et al.  Benign multiple sclerosis: a distinct clinical entity with therapeutic implications. , 2008, Current topics in microbiology and immunology.

[42]  S. Sorbi,et al.  Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. , 2006, Journal of neurology.

[43]  A. Verma Visual Function More Than 10 Years After Optic Neuritis: Experience of the Optic Neuritis Treatment Trial , 2006 .

[44]  W. L. Benedict,et al.  Multiple Sclerosis , 2007, Journal - Michigan State Medical Society.